WEE1 and ovarian carcinoma: Of the 8 genes, WEE1, a G2 checkpoint kinase, is under investigation as a potential therapeutic target in several cancer types including ovarian cancer, gastric adenocarcinoma, and squamous cell carcinoma [47–52].